Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Raloxifene (Evista) vs Whey Protein: Whey Protein has the stronger overall evidence (9 vs 5.3/10); they're alternatives for bone health — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Whey Protein wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Likely helps
11 of 12 studies with measurable effects showed benefit.
Top outcomes
Approved (postmenopausal women) / off-label (male) — clinician-directed. For osteoporosis treatment/prevention and breast-cancer risk reduction the standard, validated dose is 60 mg once daily (the cited MORE and RUTH trials used 60 mg a day, and MORE also tested 120 mg a day: both doses reduced vertebral fracture risk, and the abstract does not compare side effects between them). For off-label male gynecomastia no cited study gives a dose, none covers men or children, and there is no FDA-approved male dose and the male evidence is thin and retrospective.
Any time of day
Raloxifene hydrochloride 60 mg tablets (approved for postmenopausal osteoporosis and breast-cancer risk reduction)
20-40g per serving
Before or after training, Morning, Between meals
Whey Protein Isolate
and 1 more not shown
Months to years
Years
Throughout use
Throughout use
4-8 weeks
24-48 hours post-workout
Immediate
Within hours of consumption
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
JAMA (1999) · Rct · n=7705
MORE: multicenter, randomized, double-blind, placebo-controlled trial of raloxifene 60 or 120 mg/day in 7,705 postmenopausal women with osteoporosis, followed up to 36 months
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
JAMA (1999) · Rct · n=7705
Pre-specified breast-cancer analysis of the MORE RCT (7,705 postmenopausal women with osteoporosis), followed a median 40 months
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
J Natl Cancer Inst (2004) · Rct · n=5213
CORE: extension of the randomized MORE trial giving 4 additional years of raloxifene 60 mg/day (n=3,510) vs continued placebo (n=1,703)
Comparative Efficacy of Different Protein Supplements on Muscle Mass, Strength, and Physical Indices of Sarcopenia among Community-Dwelling, Hospitalized or Institutionalized Older Adults Undergoing Resistance Training: A Network Meta-Analysis of Randomized Controlled Trials
Nutrients (2024) · Meta analysis · n=5272
We finally included 78 RCTs (5272 participants) for analyses.
Effects of Whey Protein, Leucine, and Vitamin D Supplementation in Patients with Sarcopenia: A Systematic Review and Meta-Analysis
Nutrients (2023) · Meta analysis · n=637
Three RCTs, 637 patients with sarcopenia, of combined whey protein, leucine and vitamin D.
A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength
British Journal of Sports Medicine (2018) · Meta analysis · n=1863
49 RCTs, 1863 participants: protein supplementation increased 1RM strength (2.49 kg), fat-free mass (0.30 kg) and muscle fibre cross-sectional area during prolonged resistance training.
The points come from one dose-comparison RCT in 48 resistance-trained young men, who took 0, 10, 20 or 40 g of whey protein isolate straight after leg exercise, three hours after a high-protein breakfast (PMID 24257722). Over the next four hours myofibrillar muscle protein synthesis rose 49% above 0 g with 20 g and 56% with 40 g, and 10 g gave no added stimulation. The authors conclude 20 g is enough for the maximal response in about 80 kg men, and 40 g mainly raised amino acid oxidation and urea production. This is an acute measure of protein synthesis, not muscle growth over weeks of training, and the trial did not report tolerability, so no ceiling dose is set.
AI-estimated from published studies. Interpret as directional guidance.
Whey Protein has a higher evidence score (9/10 vs 5.3/10) and wins in 2 of 3 categories.
For bone health, Raloxifene (Evista) has a higher relevance score (76 vs 72).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
The transition years (40s): cycle changes, mood, sleep, brain fog — foundations, vitex, and starting muscle work early.
Start with 2–3 foundations, add one at a time, build by goal — without wasting money.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.